Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.
Times cited: 69
Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers.
Cancer Epidemiology Biomarkers and Prevention.
Times cited: 14
Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Ca-A Cancer Journal for Clinicians.
Times cited: 138